Suchergebnisse - "*Antirheumatic Agents"

PubPharm (30.213)

21

Therapeutic Drug Monitoring : A Tool to Optimize Treatment of Inflammatory Joint Diseases

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Syversen, S. | Gehin, J. | Goll, G. | +3

22

Infliximab Concentrations in Participants with Moderate to Severe COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Balevic, S. | Dandachi, D. | Dixon, D. | +4

23

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis : 3-year results of a prospective, multicenter, observational study

enthalten in: Arthritis research & therapy | 2024

von Yamada, Z. | Muraoka, S. | Kawazoe, M. | +5

24

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8

25

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

26

Development of a novel clinimetric tool : PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2024

von Fernández-Ávila, D. | Patiño-Hernández, D. | Moreno-Luna, S. | +17

27

Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers

enthalten in: Advanced drug delivery reviews | 2024

von Chapa-Villarreal, F. | Stephens, M. | Pavlicin, R. | +2

28

Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics

enthalten in: Advances in rheumatology (London, England) | 2024

von Kwon, O. | Choi, W. | Ahn, S. | +6

29

Difficult-to-Treat Psoriatic Arthritis : A Conceptual Approach

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Fagni, F. | Motta, F. | Schett, G. | +1

30

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis : a post hoc analysis of a phase 3b/4 randomised safety study

enthalten in: RMD open | 2024

von Buch, M. | Bhatt, D. | Charles-Schoeman, C. | +10